Agilex Demystifies the Rapidly Evolving Landscape of Drug Development Post-Covid, the field of bi...
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.
ddPCR technology provides an opportunity to streamline research and development processes, saving ti...
Small and large molecule drug development often necessitates distinct analytical methodologies. Agil...
Agilex has extensive experience developing and validating like-binding assays for specific immune-on...
Come to Our EBF Session in Barcelona to Hear how Agilex Can Make Your PK Data SPARCL SPARCL stand...
As Agilex Biolabs continues its global expansion and corporate evolution as part of the Healius network, Stephen McIntyre has been selected to take the position of Chief Executive Officer.
by Holly Stefl, Chief Commercial Officer It is with much enthusiasm that Agilex Biolabs introduce...
by Kurt Sales In the realm of bioanalytical research, immunoassays stand as a cornerstone technol...
by Holly Stefl, Chief Commercial Officer Agilex Biolabs is proud to introduce the West Coast of t...
by Dr. Kurt Sales, Chief Scientific Officer Pharmacokinetics is a key component in a drug develop...
by Dr. Kurt Sales, Chief Scientific Officer In the ever-evolving landscape of pharmaceuticals, ad...
"*" indicates required fields
